Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2008-12-15
Target enrollment:
Participant gender:
Summary
RATIONALE: Thalidomide may stop the growth of multiple myeloma by stopping blood flow to the
tumor. Prednisone may be effective in preventing relapse of multiple myeloma.
PURPOSE: Randomized phase II trial to compare the effectiveness of two doses of thalidomide
combined with prednisone following peripheral stem cell transplantation in treating patients
who have multiple myeloma.